Cervical RadiculopathyNCT03950349
FUSION EVALUATION AFTER ANTERIOR CERVICAL DISCECTOMY AND FUSION WITH STAND ALONE LOCKING CAGE WITH BLADE HRCC®
An observational study of Cervical Radiculopathy and Cervical Spinal Fusion, run by CHU de Reims at 1 site in France.
Trial summary
Cervical degenerative disease is an almost universal concomitant of human aging. Over half of the middle aged population has cervical spondylosis. This condition is often asymptomatic, but in 10% to 15% of the cases, it is associated with, or progresses to, neural compression. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cervical Radiculopathy, Cervical Spinal Fusion, Cervical Myelopathy
- How many people
- 50 participants
- Where
- 1 siteFrance
- Study dates
- 1 Jan 2019to 1 Jan 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients who consult the neurosurgical team of the REIMS University Hospital Center with diagnosis of one level cervical discopathy causing cervical radiculopathy or myelopathy with non-surgical treatment failure needing a one level anterior cervical discectomy and fusion.
Who may be able to join
- Diagnosis of one level cervical discopathy causing cervical radiculopathy or myelopathy with non-surgical treatment failure needing a one level anterior cervical discectomy and fusion
- Age > 18 years old
- Agree to take part at this study
Who cannot join
- More than one intervertebral level needs to be fused
- Antecedent of spine cervical fracture
- Active cervical malignancy
- Antecedent of cervical spine surgery
Trial locations and contacts
1 site in 1 country.
France1 site, 1 recruiting
- Recruiting
Damien JOLLY
Reims
Claude-Fabien LITRE, 03 26 78 76 59 ext. 0033, flitre@chu-reims.fr
About this study
Cervical degenerative disease is an almost universal concomitant of human aging. Over half of the middle aged population has cervical spondylosis. This condition is often asymptomatic, but in 10% to 15% of the cases, it is associated with, or progresses to, neural compression. Cervical spondylotic radiculopathy is a condition due to a root nerve compression while cervical spondylotic myelopathy is a condition due to a medullar cord compression. Root nerve or medullar cord can be compressed either by a soft disc extrusion or by arthrosis due to a degenerative disc. Anterior cervical discectomy and fusion is the standard surgical treatment of the cervical radiculopathy or cervical myelopathy when non-surgical treatment failed. The aim of this surgery is to provide a neurologic decompression associated to spine stabilization. Decompression is achieved by removal the disc and soft disc extrusion if present. Stabilization is supported by implantation of material in the interbody space like bone or cage with bone substitute. This cage provides a bone fusion matrix and an intervertebral height and stability support at the same time. To enforce the stabilization, a plate can be screwed on the anterior cervical vertebral wall. The HRCC® cage is a stand-alone cage with two rotary blades which penetrate into vertebral bone so there is no need to implant plate. One of the reasons why treatment can fail is the pseudarthrosis that is fusion failure. It mays occur as an increase of axial pain or radicular pain. The aim of this study is to demonstrate similar results on bone fusion in the surgical treatment of cervical radiculopathy or myelopathy with HRCC cage used in anterior cervical discectomy and fusion compared with other technics based on a prospective cohort study and a literature review. As secondary outcomes we will search to correlate pseudarthrosis and quality of life impact, to identify complications and to describe the sagittal balance evolution of the cervical spine. To this end, in the context of standard practices, patients who consult the neurosurgical team of the REIMS University Hospital Center with a diagnosis of a cervical radiculopathy or myelopathy with non-surgical treatment failure needing a one level anterior cervical discectomy and fusion will be proposed to be included during this pre-operative consultation. There will be pre-operative collected data about demographic data, pseudarthrosis risk factors, pre-operative symptomatology, quality of life data and pre-operative imagery data. Per-operative and hospitalization data are collected as well with surgery duration, blood lost, surgical technic, pain measurement and hospitalization duration. Next, follow-up starts with consultations at 6 weeks, 6 months and 12 months and pain, quality of life and classic X-Ray data are collected to be compared with pre-operative data. And Imagery data are collected in order to identify presence or absence of pseudarthrosis with dynamic X-Ray and CT-scan at 6 months and 12 months. A statistical analysis of the data is next performed to found significant results.
Read the detailed description
Introduction:
Cervical degenerative disease is an almost universal concomitant of human aging. Over half of the middle aged population has radiological or pathological evidence of cervical spondylosis. This condition is often asymptomatic, but in 10% to 15% of the cases, it is associated with, or progresses to, neural compression. Cervical spondylotic radiculopathy is a condition due to a root nerve compression while cervical spondylotic myelopathy is a condition due to a medullar cord compression. Root nerve or medullar cord can be compressed either by a soft disc extrusion or by osteophyte due to a degenerative disc. Anterior cervical discectomy and fusion is the gold standard treatment of those conditions when non-surgical treatment failed. The aim of this surgery is to provide a neurologic decompression associated to an intervertebral segmental stabilization. Decompression is achieved by discectomy and stabilization by cervical interbody bone fusion. This bone fusion is supported by implantation of material in the interbody space like bone or Poly-Ether-Ether-Keton cage with bone substitute. This cage provides a bone fusion matrix and an intervertebral height and stability support at the same time. To enforce the stabilization, a plate can be screwed on the anterior cervical vertebral wall. The HRCC® cage is a stand-alone cage with no need to implant plate. One risk of this technic is the secondary migration of the cage. That's why this cage is maintained with two rotary blades which penetrate into vertebral plates. It allows easier surgical procedure, with a lower duration of surgery. But one of the reasons of treatment failure is pseudarthrosis. It is defined as the absence of bone bridging the fusion area without any lucencies. It mays occur as an increase of axial pain or radicular pain. The aim of this study is to demonstrate similar results on bone fusion in the surgical treatment of cervical radiculopathy or myelopathy with HRCC cage used in anterior cervical discectomy and fusion compared with other technics based on a prospective cohort study and a literature review.
Materiel and Method In the context of standard practices, patients are included in the study when they consult the neurosurgical team of the REIMS University Hospital Center with diagnosis of one level cervical discopathy causing cervical radiculopathy or myelopathy with non-surgical treatment failure needing a one level anterior cervical discectomy and fusion. Patients are proposed to be included during this pre-operative consultation and they are informed about the protocol and the data collected. If they accept it and sign the non-opposition form, they are included in the study.
The collected data at the pre-operative consult are classic demographic data with age and sex, clinic data with weight, height and BMI, pseudarthrosis risk factors with diabete, tobacco addiction, chronic use of corticosteroid and osteoporosis with confirmed diagnosis, pre-operative symptomatology with presence of cervical radiculopathy with or without deficit, cervical myelopathy with or without pyramidal syndrome at the inferior limb and measurement of neck and radicular arm pain using a numeric scale, quality of life data with the Neck Disability Index (NDI) and the 12-Item Short Form Survey (SF-12), pre-operative imagery data with cervical IRM and the discopathy level, with cervical X-Ray in the profile incidence and measurement of cervical lordosis, measurement of regional lordosis, height. Per-operative collected data are duration of surgery, bleeding, used bone graft either allograft or autograft and final arthrodesis level. Immediate post-operative data are collected the last day of hospitalization with measurement of neck and arm pain using a numeric scale, complications with dysphagia, dysphonia, cervical compressive hematoma with urgent surgical revision, motor neurological deficit with rating if present, surgical revision, duration of the hospitalization in days, post-operative imagery data with cervical lordosis, regional lordosis, height as previously describe, and cage migration. There is a 12 months follow-up with consultations at 6 weeks, 6 months and 12 months. Collected data are for all measurement of neck and radicular arm pain using a numeric scale for the neck and for the arm, persistence of complications with dysphagia, dysphonia, and motor neurological deficit with rating if present, imagery data with cervical lordosis, regional lordosis, height as previously describe, and cage migration. At 6 months and 12 months we add quality of life data with the NDI and the SF-12, dynamic cervical X-Ray data with the measurement of the spinous process shift and CT-scan data. The diagnosis of pseudarthrosis is established on this multimodal imagery. As secondary outcomes, we will search to correlate pseudarthrosis and quality of life impact, to identify complications and to describe the sagittal balance evolution of the cervical spine.
Then, when all the data will be collected, statistical analyses will be performed with description of the cohort and descriptive statistics of all the demographic, radiographic and clinical parameters detailed above for the whole cohort: Mean (±SD) for the continuous variables and Median (±IQR) for the categorical variables. A comparison between pseudarthrosis group and fused group will be performed with univariate analysis (Student test, Wilcoxon test, Chi2 or Exact Fisher test) then a multivariate analysis will be performed with a logistic regression.
- Keywords
- Radiculopathy, myelopathy, anterior cervical fusion, stand-alone cage, pseudoarthrosis, stabilization, HRCC
- Medical subject headings
- Radiculopathy, Klippel-Feil Syndrome, Spinal Cord Diseases, Pseudarthrosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| "Anterior cervical discectomy" group | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pseudarthrosis
Pseudarthrosis diagnosis is comfirmed if :
- CT-scan documents an absence of bone bridging in the extra-graft area
- measurement of the spinous process shift which is the difference between the inter-spinous process distance on the flexion image and the inter-spinous process distance on the extension image. It is positive when it is more than 1mm at the arthrodesis level associated with a more than 4mm spine process shift at adjacent superior and inferior levels on dynamic cervical X-Ray.
Measured: 6 months
Pseudarthrosis
Pseudarthrosis diagnosis is comfirmed if :
- CT-scan documents an absence of bone bridging in the extra-graft area
- measurement of the spinous process shift which is the difference between the inter-spinous process distance on the flexion image and the inter-spinous process distance on the extension image. It is positive when it is more than 1mm at the arthrodesis level associated with a more than 4mm spine process shift at adjacent superior and inferior levels on dynamic cervical X-Ray.
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 May 2019
- Study start1 Jan 2019
- Primary completion1 Jul 2019 (estimated)
- Study completion1 Jan 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cervical RadiculopathyStudies of the same condition, open and under way.
- More trials run by CHU de ReimsThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- CHU de Reims
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03950349
- Sponsor's protocol ID
- PO18157
- Status last verified
- Apr 2019
- First submitted
- 13 May 2019
- Last updated
- 15 May 2019
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 May 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- FUSION EVALUATION AFTER ANTERIOR CERVICAL DISCECTOMY AND FUSION WITH STAND ALONE LOCKING CAGE WITH BLADE HRCC®
- ClinicalTrials.gov ID
- NCT03950349
- Acronym / sponsor ID
- PO18157
- Keywords
- Radiculopathy, myelopathy, anterior cervical fusion, stand-alone cage, pseudoarthrosis, stabilization, HRCC
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- CHU de ReimsUniversity, hospital or other
- Study start
- 1 Jan 2019 (actual)
- Primary completion
- 1 Jul 2019 (estimated)
- Study completion
- 1 Jan 2021 (estimated)
- First posted
- 15 May 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cervical degenerative disease is an almost universal concomitant of human aging. Over half of the middle aged population has cervical spondylosis. This condition is often asymptomatic, but in 10% to 15% of the cases, it is associated with, or progresses to, neural compression. Cervical spondylotic radiculopathy is a condition due to a root nerve compression while cervical spondylotic myelopathy is a condition due to a medullar cord compression. Root nerve or medullar cord can be compressed either by a soft disc extrusion or by arthrosis due to a degenerative disc. Anterior cervical discectomy and fusion is the standard surgical treatment of the cervical radiculopathy or cervical myelopathy when non-surgical treatment failed. The aim of this surgery is to provide a neurologic decompression associated to spine stabilization. Decompression is achieved by removal the disc and soft disc extrusion if present. Stabilization is supported by implantation of material in the interbody space like bone or cage with bone substitute. This cage provides a bone fusion matrix and an intervertebral height and stability support at the same time. To enforce the stabilization, a plate can be screwed on the anterior cervical vertebral wall. The HRCC® cage is a stand-alone cage with two rotary blades which penetrate into vertebral bone so there is no need to implant plate. One of the reasons why treatment can fail is the pseudarthrosis that is fusion failure. It mays occur as an increase of axial pain or radicular pain. The aim of this study is to demonstrate similar results on bone fusion in the surgical treatment of cervical radiculopathy or myelopathy with HRCC cage used in anterior cervical discectomy and fusion compared with other technics based on a prospective cohort study and a literature review. As secondary outcomes we will search to correlate pseudarthrosis and quality of life impact, to identify complications and to describe the sagittal balance evolution of the cervical spine. To this end, in the context of standard practices, patients who consult the neurosurgical team of the REIMS University Hospital Center with a diagnosis of a cervical radiculopathy or myelopathy with non-surgical treatment failure needing a one level anterior cervical discectomy and fusion will be proposed to be included during this pre-operative consultation. There will be pre-operative collected data about demographic data, pseudarthrosis risk factors, pre-operative symptomatology, quality of life data and pre-operative imagery data. Per-operative and hospitalization data are collected as well with surgery duration, blood lost, surgical technic, pain measurement and hospitalization duration. Next, follow-up starts with consultations at 6 weeks, 6 months and 12 months and pain, quality of life and classic X-Ray data are collected to be compared with pre-operative data. And Imagery data are collected in order to identify presence or absence of pseudarthrosis with dynamic X-Ray and CT-scan at 6 months and 12 months. A statistical analysis of the data is next performed to found significant results.
Detailed description
Introduction:
Cervical degenerative disease is an almost universal concomitant of human aging. Over half of the middle aged population has radiological or pathological evidence of cervical spondylosis. This condition is often asymptomatic, but in 10% to 15% of the cases, it is associated with, or progresses to, neural compression. Cervical spondylotic radiculopathy is a condition due to a root nerve compression while cervical spondylotic myelopathy is a condition due to a medullar cord compression. Root nerve or medullar cord can be compressed either by a soft disc extrusion or by osteophyte due to a degenerative disc. Anterior cervical discectomy and fusion is the gold standard treatment of those conditions when non-surgical treatment failed. The aim of this surgery is to provide a neurologic decompression associated to an intervertebral segmental stabilization. Decompression is achieved by discectomy and stabilization by cervical interbody bone fusion. This bone fusion is supported by implantation of material in the interbody space like bone or Poly-Ether-Ether-Keton cage with bone substitute. This cage provides a bone fusion matrix and an intervertebral height and stability support at the same time. To enforce the stabilization, a plate can be screwed on the anterior cervical vertebral wall. The HRCC® cage is a stand-alone cage with no need to implant plate. One risk of this technic is the secondary migration of the cage. That's why this cage is maintained with two rotary blades which penetrate into vertebral plates. It allows easier surgical procedure, with a lower duration of surgery. But one of the reasons of treatment failure is pseudarthrosis. It is defined as the absence of bone bridging the fusion area without any lucencies. It mays occur as an increase of axial pain or radicular pain. The aim of this study is to demonstrate similar results on bone fusion in the surgical treatment of cervical radiculopathy or myelopathy with HRCC cage used in anterior cervical discectomy and fusion compared with other technics based on a prospective cohort study and a literature review.
Materiel and Method In the context of standard practices, patients are included in the study when they consult the neurosurgical team of the REIMS University Hospital Center with diagnosis of one level cervical discopathy causing cervical radiculopathy or myelopathy with non-surgical treatment failure needing a one level anterior cervical discectomy and fusion. Patients are proposed to be included during this pre-operative consultation and they are informed about the protocol and the data collected. If they accept it and sign the non-opposition form, they are included in the study.
The collected data at the pre-operative consult are classic demographic data with age and sex, clinic data with weight, height and BMI, pseudarthrosis risk factors with diabete, tobacco addiction, chronic use of corticosteroid and osteoporosis with confirmed diagnosis, pre-operative symptomatology with presence of cervical radiculopathy with or without deficit, cervical myelopathy with or without pyramidal syndrome at the inferior limb and measurement of neck and radicular arm pain using a numeric scale, quality of life data with the Neck Disability Index (NDI) and the 12-Item Short Form Survey (SF-12), pre-operative imagery data with cervical IRM and the discopathy level, with cervical X-Ray in the profile incidence and measurement of cervical lordosis, measurement of regional lordosis, height. Per-operative collected data are duration of surgery, bleeding, used bone graft either allograft or autograft and final arthrodesis level. Immediate post-operative data are collected the last day of hospitalization with measurement of neck and arm pain using a numeric scale, complications with dysphagia, dysphonia, cervical compressive hematoma with urgent surgical revision, motor neurological deficit with rating if present, surgical revision, duration of the hospitalization in days, post-operative imagery data with cervical lordosis, regional lordosis, height as previously describe, and cage migration. There is a 12 months follow-up with consultations at 6 weeks, 6 months and 12 months. Collected data are for all measurement of neck and radicular arm pain using a numeric scale for the neck and for the arm, persistence of complications with dysphagia, dysphonia, and motor neurological deficit with rating if present, imagery data with cervical lordosis, regional lordosis, height as previously describe, and cage migration. At 6 months and 12 months we add quality of life data with the NDI and the SF-12, dynamic cervical X-Ray data with the measurement of the spinous process shift and CT-scan data. The diagnosis of pseudarthrosis is established on this multimodal imagery. As secondary outcomes, we will search to correlate pseudarthrosis and quality of life impact, to identify complications and to describe the sagittal balance evolution of the cervical spine.
Then, when all the data will be collected, statistical analyses will be performed with description of the cohort and descriptive statistics of all the demographic, radiographic and clinical parameters detailed above for the whole cohort: Mean (±SD) for the continuous variables and Median (±IQR) for the categorical variables. A comparison between pseudarthrosis group and fused group will be performed with univariate analysis (Student test, Wilcoxon test, Chi2 or Exact Fisher test) then a multivariate analysis will be performed with a logistic regression.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| "Anterior cervical discectomy" group | – | – |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients who consult the neurosurgical team of the REIMS University Hospital Center with diagnosis of one level cervical discopathy causing cervical radiculopathy or myelopathy with non-surgical treatment failure needing a one level anterior cervical discectomy and fusion.
Key inclusion criteria (3 listed)
- Diagnosis of one level cervical discopathy causing cervical radiculopathy or myelopathy with non-surgical treatment failure needing a one level anterior cervical discectomy and fusion
- Age > 18 years old
- Agree to take part at this study
Key exclusion criteria (4 listed)
- More than one intervertebral level needs to be fused
- Antecedent of spine cervical fracture
- Active cervical malignancy
- Antecedent of cervical spine surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Pseudarthrosis
Time frame: 6 months
Pseudarthrosis diagnosis is comfirmed if : * CT-scan documents an absence of bone bridging in the extra-graft area * measurement of the spinous process shift which is the difference between the inter-spinous process distance on the flexion image and the inter-spinous process distance on the extension image. It is positive when it is more than 1mm at the arthrodesis level associated with a more than 4mm spine process shift at adjacent superior and inferior levels on dynamic cervical X-Ray.
Pseudarthrosis
Time frame: 12 months
Pseudarthrosis diagnosis is comfirmed if : * CT-scan documents an absence of bone bridging in the extra-graft area * measurement of the spinous process shift which is the difference between the inter-spinous process distance on the flexion image and the inter-spinous process distance on the extension image. It is positive when it is more than 1mm at the arthrodesis level associated with a more than 4mm spine process shift at adjacent superior and inferior levels on dynamic cervical X-Ray.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 May 2019.
Related trials for Cervical Radiculopathy
Recruiting
Ultrasound-Guided Electrical Dry Needling for Chronic Cervical Radiculopathy
Cervical Radiculopathy
Not yet recruitingObservational study
Correlation Between Forward Head Posture and Executive Functions in Cervical Radiculopathy
Cervical Radiculopathy, Forward Head Posture
Recruiting
Myo-Electrical and Nerve Root Function Response to Focused Extracorpeal Shock Wave in Cervical Radiculopathy
Cervical Radiculopathy
Not yet recruiting
Endoscopic Posterior Cervical Foraminotomy Versus Anterior Cervical Discectomy and Fusion for Cervical Radiculopathy
Cervical Disc Herniation, Cervical Foraminal Stenosis
RecruitingObservational study
Cervical Spinal Cord Signal Abnormalities in Patients With Cervical Radicular Pain
Cervical Radiculopathy, Cervical Myelomalacia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cervical Radiculopathy and Cervical Spinal Fusion, run by CHU de Reims at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 15 May 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Claude-Fabien LITRE (03 26 78 76 59 ext. 0033, flitre@chu-reims.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pseudarthrosis (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2019.